Seroepidemiology of hepatitis B in Greek children 6 years after the implementation of universal vaccination

Infection

Volumn 36, Issue 2, 2008, Pages 135-139

  Papaevangelou, V ^a   Hadjichristodoulou, C ^b   Cassimos, D C ^c   Pantelaki, K ^d   Tzivaras, A ^d   Hatzimichael, A S ^c   Theodoridou, M ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^d Department of Cardiology   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; CHILD; CONFIDENCE INTERVAL; GEOGRAPHIC DISTRIBUTION; GREECE; HEPATITIS B; HUMAN; IMMIGRANT; IMMUNIZATION; INFANT; NEWBORN; SEROEPIDEMIOLOGY; TREATMENT OUTCOME; VACCINATION;

ADOLESCENT; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; GREECE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MASS IMMUNIZATION; SEROEPIDEMIOLOGIC STUDIES;

EID: 42249083219     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-007-7096-6     Document Type: Article

References (34)

1. Kattamis C, Papaevangelou G: Workshop Group: Greece. Vaccine 1995; 13: S97-S98.
2. Stamouli M, Gizaris V, Totos G, Papaevangelou G: Decline of hepatitis B infection in Grece. Eur J Epidemiol 1999; 15: 447-449.
3. Kyriakis KP, Foudoulaki LE, Papoulia EI, Sofroniadou KE: Seroprevalence of hepatitis B surface antigen (HbsAg) among first time and sporadic blood donors in Greece 1991-1996. Transfus Med 2000; 10: 175-180.
4. Tassopoulos N, Papatheodoridis G: Epidemiology of hepatitis B infection. Hellenic J Gastrenterol 1993; 6: 67-73.
5. Papaevangelou G: Hepatitis B immunization programme: lessons learnt in Greece. Vaccine 1998; 16: S45-S47.
6. Osborne K, Weinberg J, Miller E: The European sero-epidemiological network. Eurosurveillance 1997; 2: 29-31.
7. Pebody RG, Edmunds WJ, Conyn-van Spaendonck M, Olin P, Berbers G, Rebiere I, et al. The seroepidemiology of rubella in Western Europe. Epidemiol Infect 2000; 125: 347-357.
8. Edmunds WJ, Pebody RG, Aggerback H, Baron S, Berbers G, Conyn-van Spaendonck MA, et al. The seroepidemiology of diphtheria in Western Europe. ESEN project. European Seroepidemiology Network. Epidemiol Infect 2000; 125: 113-125.
9. Kafatos G, Anastassopoulou C, Nardone A, Andrews N, Barbara C, Boot H, et al. The European sero-epidemiology network 2: standardization of assay results for hepatitis B virus. J Viral Hepatitis 2007; 14: 260-268.
10. Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL, et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastornterology 2007; 132: 1287-1293.
11. Dominguez A, Bruguera M, Vidal J, Plans P, Salleras L: Changes in the seroepidemiology of hepatitis B infection in Catalonia 1989-1996. Vaccine 2000; 18: 2345-2350.
12. Salleras L, Dominguez A, Bruguera M, Cardenosa N, Batalla J, Carmona G, et al. Dramatic decline in acute hepatitis B infection and disease incidence rates among adolescents and young people after 12 years of a mass hepatitis B vaccination programme of pre-adolescents in the schools of Catalonia (Spain). Vaccine 2005; 23: 2181-2184.
13. Al-Faleh FZ, Al-Jeffri M, Ramia S, Al-Rashed R, Arif M, Rezeig M, et al. Seroepidemiolgy of hepatitis B virus infection in Saudi Children after a mass hepatitis B vaccination programme. J Infect 1999; 38: 167-170.
14. Mossong J, Putz L, Patiny S, Schneider F: Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg. Epidemiol Infect 2006; 134: 808-813.
15. Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA, Mphahlele MJ: The first five years of universal hepatitis B vaccination in South Africa: evidence fro elimination of HBsAg carriage in under 5-year-olds. Vaccine 2001; 19: 3919-3926.
16. Harpaz R, McMahon BJ, Margolis HS, Shapiro CN, Havron D, Carpenter G, et al. Elimination of new chronic hepatitis B infections: results of the Alaska immunization programme. J Infect Dis 2000; 181: 413-418.
17. Centers for Disease Control and Prevention Acute hepatitis B among children and adolescents: United States 1990-2002. MMWR 2004; 53: 1015-1018.
18. Panagiotopoulos T, Valassi-Adam E, Sarafidou E, Mandeki A, Stratiki Z, Benos A, et al. Greek study on vaccination coverage. Arch Hellenic Med 1999; 16: 154-162.
19. Bitsori M, Ntokos M, Kontarakis N, Sianava O, Ntouros T, Galanakis E: Vaccination coverage among adolescents in certain provinces of Greece. Acta Paediatr 2005; 94: 1122-1125.
20. Stamouli M, Gizaris V, Totos G, Papaevangelou G: Decline of hepatitis B infection in Greece. Eur J Epidemiol 1999; 15: 447-449.
21. German V, Giannakos G, Kopteridis P, Liaskonis K, Falagas ME: Serologic indices of hepatitis B virus infection in military recruits in Greece (2004-2005). BMC Infect Dis 2006; 6: 163.
22. World Health Organization.WHO vaccine-preventable diseases: monitoring system 2006 global summary. World Health Organization, Geneva, Switzerland, 2006.
23. Stroffolini T: The changing pattern of hepatitis B virus infection over the past three decades in Italy. Dig Liver Dis 2005; 37: 622-627.
24. Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY, Chen DS: Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan. JAMA 1996; 276: 906-908.
25. Shepard CW, Finelli L, Fiore AE, Bell BP: Epidemiology of Hepatitis B and Hepatitis B Virus Infection in United States Children. Pediatr Infect Dis J 2005; 24: 755-760.
26. Hsu HM, Lu CF, Lee SC, Lin SR, Chen DS: Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis mass immunization. J Infect Dis 1999; 179: 367-370.
27. Clements CJ, Baoping Y, Crouch A, Hipgrave D, Mansoor O, Nelson CB, et al. Progress in the control of hepatitis B infection in the Western Pacific Region. Vaccine 2006; 24: 1975-1982.
28. Yusuf HR, Daniels D, Smith P, Coronado V, Rodewald L: Association between administration of hepatitis B vaccine at birth and completion of the hepatitis B and 4:3:1:3 vaccine series. JAMA 2000; 284: 978-983.
29. MMWR: Progress in hepatitis B prevention through universal infant vaccination. China 1997-2006. MMWR; 56: 441-445.
30. Dalekos Gn, Zervou E, Karabini F, Tsianos EB: Prevalence of hepatitis A, B and D in Albanian refugees. Eur J Gastrentrol Hepatol 1995; 7: 553-558.
31. Malamitsi-Puchner A, Papacharitonos S, Sotos D, et al. Prevalence study of different hepatitis markers among pregnant Albanian refugees in Greece. Eur J Epidemiol 1996; 12: 297-301.
32. Skliros FA, Sotiropoulos A, Peppas T, Sofroniadou K, Lionis C: High prevalence of infection markers in refugees from Eastern countries. Ital Gastroenterol Hepatol 1999; 1: 84-85.
33. Skliros F, Lionis C, Foudoulaki T, Sotiropoulos A, Kouroumalis F, Spandidos D: Hepatitis B abd C markers in Kurdish refugee camp in Greece. J Gastroenterol Hepatol 2001; 16: 839-840.
34. Papaevangelou V, Hadjichristodoulou C, Cassimos DC, Theodoridou M: Adherence to the screening program for HBV infection in pregnant women delivering in Greece. BMC ID 2006; 6: 84.